Advertisement
New Zealand markets closed
  • NZX 50

    11,717.43
    -117.59 (-0.99%)
     
  • NZD/USD

    0.6081
    -0.0003 (-0.04%)
     
  • NZD/EUR

    0.5681
    +0.0003 (+0.05%)
     
  • ALL ORDS

    8,013.80
    +11.00 (+0.14%)
     
  • ASX 200

    7,767.50
    +7.90 (+0.10%)
     
  • OIL

    82.50
    +0.76 (+0.93%)
     
  • GOLD

    2,346.10
    +9.50 (+0.41%)
     
  • NASDAQ

    19,789.03
    +37.98 (+0.19%)
     
  • FTSE

    8,221.15
    +41.47 (+0.51%)
     
  • Dow Jones

    39,164.06
    +36.26 (+0.09%)
     
  • DAX

    18,305.69
    +95.14 (+0.52%)
     
  • Hang Seng

    17,718.61
    +2.14 (+0.01%)
     
  • NIKKEI 225

    39,583.08
    +241.54 (+0.61%)
     
  • NZD/JPY

    97.6570
    -0.0760 (-0.08%)
     

Erratum to the Press Release "Annual Shareholder’s Meeting of Groupe Berkem: Availability of Preparatory Documents and Participation and Voting Procedures" Dated June 10, 2024

BLANQUEFORT, France, June 11, 2024--(BUSINESS WIRE)--Regulatory News:

Groupe Berkem (Paris:ALKEM), a leading player in bio-based chemicals (ISIN code: FR00140069V2 - Ticker: ALKEM), informs its shareholders and the financial community that, contrary to what was indicated in the press release issued on June 10, 2024, the Company's Annual Shareholder’s Meeting will be held on Tuesday June 25, 2024 at 10:00 a.m., at its Gardonne industrial site, located at Marais Ouest, 643 Rte de Gageac, 24680 Gardonne, in accordance with what is indicated in the notice of meeting published in the Bulletin des annonces légales obligatoires n°70 dated June 10, 2024.

ABOUT GROUPE BERKEM

Founded in 1993 by Olivier Fahy, Chairman and Chief Executive Officer, Groupe Berkem is a leading force in the bio-based chemicals market. Its mission is to advance the environmental transition of companies producing the chemicals used in everyday life (Construction & Materials, Health, Beauty & Nutrition, Hygiene & Protection, and Industry). By harnessing its expertise in both plant extraction and innovative formulations, Groupe Berkem has developed bio-based boosters—unique high-quality bio-based solutions augmenting the performance of synthetic molecules. Groupe Berkem achieved revenue of €51.8 million in 2022. The Group has almost 200 employees working at its head office (Blanquefort, Gironde) and 3 production facilities in Gardonne (Dordogne), La Teste-de-Buch (Gironde), Chartres (Eure-et-Loir) and Valence (Spain).

ADVERTISEMENT

Groupe Berkem has been listed on Euronext Growth Paris since December 2021 (ISIN code: FR00140069V2 - ALKEM).
www.groupeberkem.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20240611891489/en/

Contacts

Groupe Berkem
Olivier Fahy, Chairman and CEO
Anthony Labrugnas, Chief Financial Officer

Phone: +33 (0)5 64 31 06 60
investisseurs@berkem.com

NewCap
Investor Relations
Mathilde Bohin / Nicolas Fossiez

Phone: +33 (0)1 44 71 94 94
berkem@newcap.eu

NewCap
Media Relations
Nicolas Merigeau / Antoine Pacquier

Phone: +33 (0)1 44 71 94 94
berkem@newcap.eu